Based on the Arch Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Arch Therapeutics Inc is not available over the next 12 months. Arch Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Arch Therapeutics Inc is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Arch Therapeutics Inc’s stock price was USD 0.39. Arch Therapeutics Inc’s stock price has changed by +29.91% over the past week, +8.91% over the past month and -35.00% over the last year.
No recent analyst target price found for Arch Therapeutics Inc
No recent average analyst rating found for Arch Therapeutics Inc
Company Overview Arch Therapeutics Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Arch Therapeutics Inc (ARTH)
Loading...
Unadjusted Closing Price for Arch Therapeutics Inc (ARTH)
Loading...
Share Trading Volume for Arch Therapeutics Inc Shares
Loading...
Compare Performance of Arch Therapeutics Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for ARTH
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Arch Therapeutics Inc (Sector: Biotechnology )
Frequently Asked Questions About Arch Therapeutics Inc (ARTH) Stock
Stock Target Advisor's fundamental analysis for Arch Therapeutics Inc's stock is Neutral.
Unfortunately we do not have enough data on ARTH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARTH's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARTH's stock to indicate if its overvalued.
The last closing price of ARTH's stock was USD 0.39.
Unfortunately we do not currently have any market capitalization data for ARTH's stock.
Unfortunately we do not have enough analyst data on ARTH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Arch Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for Arch Therapeutics Inc.
Sorry we do not have any infomation available on Arch Therapeutics Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Frequently Asked Questions About Arch Therapeutics Inc (ARTH) Stock
Stock Target Advisor's fundamental analysis for Arch Therapeutics Inc's stock is Neutral.
Unfortunately we do not have enough data on ARTH's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARTH's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARTH's stock to indicate if its overvalued.
The last closing price of ARTH's stock was USD 0.39.
Unfortunately we do not currently have any market capitalization data for ARTH's stock.
Unfortunately we do not have enough analyst data on ARTH's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Arch Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for Arch Therapeutics Inc.
Sorry we do not have any infomation available on Arch Therapeutics Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARTH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
